Pharmacy Drugs
Recent Posts
- CRT May Benefit Patients wth Mild Heart Failure (CME/CE)
- New Standard Reduces Heparin Potency
- Clinical Trial Launched In India To Improve Treatment For People Bitten By Rabid Animals
- VeriChip Corporation Announces Phase II Development Of In Vivo Glucose-Sensing RFID Microchip With RECEPTORS LLC
- Cardiac Stem Cell Trial Seeks To Treat Some Heart Attack Patients
Random Posts
- Royal Pharmaceutical Society Vows To Improve The Lot Of Pharmacists After Symposium
- Depomed Completes Enrollment Of Phase 3 Clinical Program Of DM-1796 In Post-Herpetic Neuralgia
- BioLineRx Initiates Phase I/II Trial Of BL-5010, A Novel Formulation For The Non Surgical Removal Of Skin Lesions
- Arizona Heart Institute Enrolls First Patient In Anaconda(TM) Investigational Study For The Treatment Of Abdominal Aortic Aneurysm
- West Nile Virus Cases Lower Than Reported
- Lymphoma Patients Benefit From Exercise
- Mylan's Matrix Receives First And Only Tentative FDA Approval Under PEPFAR For Generic Version Of Atripla® HIV Treatment
- FDA Warns Drug Maker on Cold Medicines with Vitamin C
- NCPA: Pharmacy Provisions In Senate Finance Committee Health Care Reform Bill Benefit Patients, Lower Costs, Deserve Support
- Pirfenidone May Help Lung Function In IPF Patients According To Large Clinical Trial
Omnicell, Inc., Provides Grant For Pharmacy Practice Model Initiative
Posted by: admin in Pharmacy Drugs on April 30th, 2010
The American Society of Health-System Pharmacists (ASHP) and the ASHP Research and Education Foundation today announced a commitment from Omnicell, Inc., to provide “Gold Level” funding sponsorship in support of the Pharmacy Practice Model Initiative (PPMI). The PPMI, launched earlier this year, is the next major step in the evolution of pharmacy practice in hospitals and health systems.
A joint project of ASHP and the ASHP Foundation, the PPMI has three components, including an invitational summit to be held in 2010, a social marketing campaign to promote change, and demonstration projects. ASHP is currently seeking additional funding for these key activities.
“We are extremely pleased that Omnicell is supporting this important initiative,” said Stephen J. Allen, M.S., FASHP, Executive Vice President of the ASHP Foundation. “Omnicell’s commitment will help the initiative to redefine, reconstruct, and reinvent pharmacy practice in hospitals and health systems. As an industry leader in hospital pharmacy automation, Omnicell’s support is a strong indication of its commitment to support the optimization of the pharmacist’s patient care role.”
The PPMI will build on the landmark work of the Hilton Head conference, held by ASHP in 1985. The Hilton Head conference brought together a group of visionary pharmacists who helped establish the concept that the practice of pharmacy is a clinical profession and that the role of pharmacists in health systems should be focused on direct care of patients as part of multidisciplinary care teams.
“Omnicell welcomes the opportunity to support this critical need to further enhance pharmacy practice within health systems by enabling the collection, dissemination, and demonstration of best practices to health-system pharmacists,” said Randall Lipps, president, chairman and CEO of Omnicell. “We are committed to continually innovating medication management processes to allow pharmacists to devote more time to direct patient care activities, and the goals of the PPMI are well-aligned with the Omnicell mission.”
The Pharmacy Practice Model Initiative will:
1. Create a framework for ensuring the provision of safe, effective, efficient, accountable, and evidence-based care for all hospital/health-system patients;
2. Determine patient care-related services that should be consistently provided by departments of pharmacy in hospitals and health systems and increase demand for pharmacy services by patients/caregivers, health care professionals, health care executives, and payers;
3.Identify the available technologies to support implementation of the practice model, and identify emerging technologies that could impact the practice model;
4. Support the optimal use and deployment of hospital and health-system pharmacy resources through development of a template for a practice model which is operational, practical, and measurable; and
5. Identify specific actions pharmacists should take to implement practice model change including determination of the necessary staff (pharmacy leaders, pharmacists, and technicians) skills and competencies required to implement this model.
To learn more, visit http://www.ashp.org/ppmi.
Source
ASHP
The ASHP Foundation
Omnicell, Inc.
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.





